Showing 1091-1100 of 2853 results for "".
Teleneuro-ophthalmology
https://practicalneurology.com/diseases-diagnoses/headache-pain/teleneuro-ophthalmology/31670/Something can almost always be offered virtually for people with neuro-ophthalmologic conditions.Dementia Insights:
Short- and Long-Term Cognitive Consequences of Acute Non-Neurological Hospitalizationhttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-brshort--and-long-term-cognitive-consequences-of-acute-non-neurological-hospitalization/30786/Most neurologists are not surprised to hear that a patient has cognitively or physically deteriorated after hospitalization, but what is the evidence and mechanism for this?MS Minute: Oral Therapies for MS
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ms-minute-oral-therapies-for-ms/31607/The advent of oral therapies has ushered in a new phase of disease-modifying treatments.Understanding Disparities Associated with Alzheimer Disease and Related Dementias
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/understanding-disparities-associated-with-alzheimer-disease-and-related-dementias/32142/Clinicians need to take into consideration a variety of factors resulting in disparities in health outcomes in people with dementia, including socioeconomic status, race, ethnicity, environment, life experiences, and culture.Disparities in Alzheimer Disease and Alzheimer-Related Dementias: Considerations for Clinical Decision-Making and Treatment
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/disparities-in-alzheimer-disease-and-alzheimer-related-dementias-considerations-for-clinical-decision-making-and-treatment/32016/Taking into account social determinants of health and identifying solutions to improve patient care.Pharmacologic Management of Behavioral Challenges and Psychiatric Comorbidities in People With Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/pharmacologic-management-of-behavioral-challenges-and-psychiatric-comorbidities-in-people-with-epilepsy/39969/Treatment of behavioral and psychiatric comorbidities in people with epilepsy requires careful consideration of underlying causes, symptom profile, antiseizure medications, and epilepsy type.Headache Medicine Update: What’s New in CGRP Functional Blocking Agents
https://practicalneurology.com/diseases-diagnoses/headache-pain/headache-medicine-update-whats-new-in-cgrp-functional-blocking-agents/32126/CGRP blocking agents have demonstrated success in migraine treatment and can be used in various settings, in different combinations, and for different headache conditions.Relapse Management in Multiple Sclerosis: Corticosteroids Remain the Linchpin of Therapies
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/relapse-management-in-multiple-sclerosis-corticosteroids-remain-the-linchpin-of-therapies/32084/Several modalities are available for the treatment of multiple sclerosis relapse, including corticosteroids, intravenous immunoglobulins, and therapeutic apheresis.Updates in Bruton Tyrosine Kinase Inhibition for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/updates-in-bruton-tyrosine-kinase-inhibition-for-multiple-sclerosis/31975/Ongoing clinical trials will elucidate potential advantages and safety of these novel medications for future treatment of multiple sclerosis.Neurologic Manifestations & Associations of COVID-19
https://practicalneurology.com/diseases-diagnoses/imaging-testing/neurologic-manifestations-associations-of-covid-19/31739/High-quality epidemiologic data is still urgently needed to better understand neurologic effects of COVID-19.